Association of baseline inflammatory markers and the development of negative symptoms in individuals at clinical high risk for psychosis

DR Goldsmith, E Haroon, AH Miller, J Addington… - Brain, behavior, and …, 2019 - Elsevier
Negative symptoms are common in individuals at clinical high-risk (CHR) for psychosis and
are associated with worse functional outcomes. Inflammation may be one mechanism …

The Maudsley environmental risk score for psychosis

E Vassos, P Sham, M Kempton, A Trotta… - Psychological …, 2020 - cambridge.org
BackgroundRisk prediction algorithms have long been used in health research and practice
(eg prediction of cardiovascular disease and diabetes). However, similar tools have not …

Cognitive behavioral therapy for prodromal stage of psychosis—outcomes for transition, functioning, distress, and quality of life: a systematic review and meta-analysis

Y Zheng, T Xu, Y Zhu, C Li, J Wang… - Schizophrenia …, 2022 - academic.oup.com
Objective This study aimed to provide insight into the efficacy of cognitive-behavioral therapy
for psychosis (CBTp) in patients with “clinical high risk of psychosis (CHR-P)”. Methods …

Specificity of incident diagnostic outcomes in patients at clinical high risk for psychosis

JR Webb, J Addington, DO Perkins… - Schizophrenia …, 2015 - academic.oup.com
It is not well established whether the incident outcomes of the clinical high-risk (CHR)
syndrome for psychosis are diagnostically specific for psychosis or whether CHR patients …

The NEURAPRO biomarker analysis: long-chain omega-3 fatty acids improve 6-month and 12-month outcomes in youths at ultra-high risk for psychosis

GP Amminger, B Nelson, C Markulev, HP Yuen… - Biological …, 2020 - Elsevier
Background NEURAPRO was a multicenter, placebo-controlled trial of long-chain omega-3
polyunsaturated fatty acids (n-3 PUFAs)(fish oil) in 304 individuals at ultra-high risk for …

NICE CG178 Psychosis and Schizophrenia in Adults: Treatment and Management–an evidence-based guideline?

M Taylor, U Perera - The British Journal of Psychiatry, 2015 - cambridge.org
National Institute for Health and Care Excellence (NICE) clinical guideline (CG) 178 was
published in 2014. NICE guidelines occupy an important international position. We argue …

Increased occipital gyrification and development of psychotic disorders in individuals with an at-risk mental state: a multicenter study

D Sasabayashi, Y Takayanagi, T Takahashi, S Koike… - Biological …, 2017 - Elsevier
Background Anomalies of brain gyrification have been reported in schizophrenia, possibly
reflecting its neurodevelopmental pathology. However, it remains elusive whether …

Baseline demographics, clinical features and predictors of conversion among 200 individuals in a longitudinal prospective psychosis-risk cohort

G Brucato, MD Masucci, LY Arndt… - Psychological …, 2017 - cambridge.org
BackgroundDSM-5 proposes an Attenuated Psychosis Syndrome (APS) for further
investigation, based upon the Attenuated Positive Symptom Syndrome (APSS) in the …

Prepubertal environmental enrichment prevents dopamine dysregulation and hippocampal hyperactivity in MAM schizophrenia model rats

X Zhu, AA Grace - Biological psychiatry, 2021 - Elsevier
Background Schizophrenia (SCZ) is a neurodevelopmental disorder with a progressive,
prolonged course. Early prevention for SCZ is promising but overall lacks support from …

Canadian guidelines for the pharmacological treatment of schizophrenia spectrum and other psychotic disorders in children and youth

S Abidi, I Mian, I Garcia-Ortega… - The Canadian …, 2017 - journals.sagepub.com
Objective: Schizophrenia spectrum and other psychotic disorders often have their onset in
adolescence. The sequelae of these illnesses can negatively alter the trajectory of …